🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK2982772 is a first-in-class, highly selective, receptor-interacting prot...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-27
Trial ID
NCT03266172
Treatments Being Tested
The purpose of this study was to evaluate the safety, efficacy and pharmaco...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01487161
This is an open-label, randomized, cross over single oral dose study to com...
Status
Withdrawn
Location
Research Site
Start Date
2015-11
Trial ID
NCT02560363
The purpose of this research study is to initiate a pharmacotherapy protoco...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-01-05
Trial ID
NCT04977271
Treatments Being Tested
The purpose of this study is to assess the relative effectiveness, safety, ...
Status
Recruiting
Location
University of Pennsylvania
Start Date
2026-05-01
Trial ID
NCT07542756
The purpose of this study is to evaluate ORM-12741 concentrations in blood ...
Status
Completed
Location
Clinical Research Services Turku - CRST Oy
Start Date
2014-10
Trial ID
NCT02303860
Treatments Being Tested
The purpose of this study is to evaluate the gastro-intestinal tolerability...
Status
Completed
Location
GB801
Start Date
2014-04
Trial ID
NCT02112903
To establish pharmacokinetics (PK), pharmacodynamics (PD), and adverse even...
Status
Completed
Location
Tufts-New England Medical Center
Start Date
2010-10
Trial ID
NCT01210560
Treatments Being Tested
This is a Phase 1, randomized, open label, 4-period, 6-sequence, partial cr...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2017-09-11
Trial ID
NCT03112148
Treatments Being Tested
This study is a randomized, open-label, 5-period, 5-treatment, single-dose,...
Status
Completed
Location
Research Site
Start Date
2016-12-20
Trial ID
NCT02963116
Treatments Being Tested